Goldman Sachs analyst Ryan Nash maintains Enact Holdings (NASDAQ:ACT) with a Neutral and lowers the price target from $26.5 to $25.
Why Water Technology Company Xylem Shares Are Seeing Blue Skies Today
Xylem shines in Q4 FY23, boasting 41% revenue growth to $2.12 billion, surpassing market expectations. Orders and backlog surge, indicating robust demand and promising future prospects.
With impressive financial results and a confident outlook, Xylem positions itself as a leader in the industry, projecting adjusted EPS of $4.00-$4.20 for FY24.
